NCT04170621View on ClinicalTrials.gov

Feasibility Study of the FARAPULSE Endocardial Multi Ablation System in the Treatment of Persistent Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 18, 2019

Primary Completion Date

July 14, 2021

Study Completion Date

July 14, 2021

Conditions
Persistent Atrial Fibrillation
Interventions
DEVICE

Ablation

Ablation using the FARAPULSE Endocardial Multi Ablation System

Trial Locations (2)

21000

University Hospital of Split, Split

Unknown

Nemocnice Na Homolce, Prague

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY